Pharmaceuticals
Gurugram fake Mounjaro racket busted: Two arrested, Rs 71 lakh seized, nationwide alert issued
Reported by AI Image generated by AI
Gurugram's Drugs Control Office busted a counterfeit Mounjaro (tirzepatide) injections racket on April 18, arresting Avi Sharma and Mujammil Khan after intercepting a cab in DLF Phase-IV and raiding Sharma's flat. Fake injections worth over Rs 71 lakh were seized, with packaging machines recovered. A nationwide alert has been issued, and officials warn of health risks from such fakes.
A new analysis of clinical trials indicates that semaglutide, the active ingredient in Ozempic and Wegovy, helps older adults with obesity lose substantial weight and improve heart health markers. The findings come from data on participants aged 65 and above who received the once-weekly medication alongside lifestyle changes.
Reported by AI
Acadia Pharmaceuticals Inc. released a slide deck for its first-quarter 2026 earnings call on May 6.
Egyptian Health Minister Khaled Abdel Ghaffar met Kenyan Health Minister Aden Bare Duale on the sidelines of the Global Health Summit in Nairobi to explore expanding cooperation in healthcare and pharmaceuticals. Discussions focused on transferring Egyptian expertise and fast-tracking pending strategic agreements. The initiative underscores Egypt's commitment to continental health security.
Reported by AI
Sun Pharmaceutical Industries' shares surged more than 9% following the announcement of its $11.75 billion acquisition of US-based Organon & Co. The deal targets bolstering the Indian company's innovative medicines and positioning it strongly in biosimilars and women's health markets. Organon is recognized as a global leader in women's health.
Chile's Public Health Institute (ISP) issued a pharmaceutical alert ordering the voluntary recall of Laboratorio Chile S.A.'s loratadine syrup 5 mg/5 ml after detecting out-of-specification impurities in stability studies. The action targets batches EWOA, EWOB, and EWOC, expiring in September 2026.
Reported by AI
Egypt's Prime Minister Mostafa Madbouly chaired a high-level meeting on Sunday to review the availability of pharmaceutical products and active raw materials in the domestic market. The session, attended by ministers and officials, emphasized ensuring adequate strategic drug reserves and monitoring supply chains while advancing localization efforts. A detailed report confirmed sufficient inventories to meet local demand.
Egypt's industry minister meets pharma chamber to boost growth, exports
May 04, 2026 23:53Biontech to close nearly all production sites in Germany
May 04, 2026 23:12Pharco Pharmaceuticals plans EGP 1.5bn investments for production and export expansion
May 04, 2026 21:50Nuvation Bio holds Q1 2026 earnings call
May 04, 2026 18:31BioMarin holds Q1 2026 earnings call
April 22, 2026 02:24Pharco launches EGP 500m eye drops production line in Alexandria
April 13, 2026 22:13FDA approves Travere Therapeutics' FILSPARI for FSGS
April 02, 2026 19:20Trump administration adjusts metal tariffs, imposes 100% pharmaceutical duty
April 01, 2026 16:58FDA approves Eli Lilly’s once-daily obesity pill Foundayo
March 30, 2026 15:21Evolocumab reduces heart attack risk by 31% in high-risk diabetes patients